These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Roles of brain prostaglandin E2 and thromboxane A2 in the activation of the central sympatho-adrenomedullary outflow in rats.
    Author: Murakami Y, Okada S, Nishihara M, Yokotani K.
    Journal: Eur J Pharmacol; 2002 Oct 11; 452(3):289-94. PubMed ID: 12359269.
    Abstract:
    We examined the effects of centrally administered active metabolites of the arachidonic acid cascade on activation of the central sympatho-adrenomedullary outflow using urethane-anaesthetized rats. Intracerebroventricularly (i.c.v.) administered prostaglandin E(2) (0.3 nmol/animal) significantly elevated plasma levels of noradrenaline while levels of adrenaline were not affected. Prostaglandin D(2), prostaglandin F(2 alpha) and prostaglandin I(2) at the same dose (0.3 nmol/animal, i.c.v.) had no effect on plasma levels of either catecholamine. Thromboxane A(2) mimetic, 7-[3-[3-hydroxy-4-(4-iodophenoxy)-1-butenyl]-7-oxabicyclo [2.2.1]hept-2-yl], [1S-[1 alpha,2 alpha(Z),3beta(1E,3S),4 alpha]]-5-heptenoic acid (I-BOP) (5 and 10 pmol/animal) microinjected into the paraventricular nucleus of the hypothalamus significantly elevated plasma levels of adrenaline, but had little effect on plasma levels of noradrenaline. The I-BOP-induced (10 pmol/animal) elevation of plasma adrenaline levels was abolished by (+)-(1R,2R,3S,4S)-(5Z)-7-(3-[4-3H]-phenylsulphonyl-aminobicyclo[2.2.1]hept-2-yl)hept-5-enoic acid sodium salt [(+)-S-145] (a blocker of thromboxane A(2) receptors) [625 nmol (250 micro g)/animal, i.c.v.]. These results suggest that brain prostaglandin E(2) and thromboxane A(2) are respectively involved in the activation of the central sympathetic and adrenomedullary outflow in rats.
    [Abstract] [Full Text] [Related] [New Search]